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A novel ZRS variant causes preaxial polydactyly type I by
increased sonic hedgehog expression in the developing
limb bud
Caixia Xu, PhD1, Xiaoming Yang, MD2,3, Hang Zhou, MD2,3, Yongyong Li, BS1, Chao Xing, PhD 4,
Taifeng Zhou, MD2,3, Dongmei Zhong, BS1, Chengjie Lian, PhD2,3, Mei Yan, BS5, Tao Chen, BS5,
Zhiheng Liao, MD2,3, Bo Gao, PhD6, Deying Su, BS2,3, Tingting Wang, MS2,3, Swarkar Sharma, PhD 7,
Chandra Mohan, PhD8, Nadav Ahituv, PhD9,10, Sajid Malik, PhD 11, Quan-Zhen Li, PhD5 and
Peiqiang Su, MD, PhD 2,3
Purpose: Preaxial polydactyly (PPD) is a common congenital hand
malformation classified into four subtypes (PPD I–IV). Variants in
the zone of polarizing activity regulatory sequence (ZRS) within
intron 5 of the LMBR1 gene are linked to most PPD types.
However, the genes responsible for PPD I and the underlying
mechanisms are unknown.
Methods: A rare large four-generation family with isolated PPD I
was subjected to genome-wide genotyping and sequence analysis. In
vitro and in vivo functional studies were performed in Caco-2 cells,
293T cells, and a knockin transgenic mouse model.
Results: A novel g.101779T>A (reference sequence: NG_009240.2;
position 446 of the ZRS) variant segregates with all PPD I–affected
individuals. The knockin mouse with this ZRS variant exhibited
PPD I phenotype accompanying ectopic and excess expression of
Shh. We confirmed that HnRNP K can bind the ZRS and SHH
promoters. The ZRS mutant enhanced the binding affinity for
HnRNP K and upregulated SHH expression.
Conclusion: Our results identify the first PPD I disease-causing
variant. The variant leading to PPD I may be associated with
enhancing SHH expression mediated by HnRNP K. This study adds
to the ZRS-associated syndromes classification system for PPD and
clarifies the underlying molecular mechanisms.
Genetics in Medicine (2020) 22:189–198; https://doi.org/10.1038/s41436-
019-0626-7
Keywords: preaxial polydactyly; ZRS; sonic hedgehog; gene
regulation
INTRODUCTION
Preaxial polydactyly (PPD, OMIM 603596), extra digits
occurring on the preaxial side of the hands, is the most
common congenital hand malformation, with the prevalence
ranging from 5 to 19 per 10,000 live births.1 According to
Temtamy–McKusick classification, PPD is generally classified
into four subtypes: type I (PPD I, OMIM 174400), thumb/
hallux polydactyly; type II (PPD II, OMIM 174500),
triphalangeal thumbs (TPT); type III (PPD III, OMIM
174600), polydactyly of an index finger; and type IV (PPD
IV, OMIM 174700), polysyndactyly.2,3 Among all four types,
PPD I occurs most frequently, but presently, its underlying
genetic basis is not well understood.4,5
PPD manifests either by itself or as a part of a syndrome.
When it occurs in isolation, autosomal dominant variations in
a single gene are typically involved.6 Genetic variants in the
zone of polarizing activity regulatory sequence (ZRS, OMIM
605522), a limb-specific cis-regulator located in intron 5 of the
LMBR1 on chromosome 7q36, have been linked to most PPD
types, including PPD II, PPD II/III, triphalangeal
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thumb–polysyndactyly syndrome (TPTPS, OMIM 188770),
syndactyly type IV (SD4, OMIM 186200), and Werner
mesomelic syndrome (WMS, OMIM 188770),7–12 indicating
that variants at ZRS can lead to different PPD phenotypes. In
this region, more than 20 point variants, 10 duplications, 1
triplication, and a base pair insertion have been reported to be
associated with PPD.3,13,14 Further study indicated that this
highly conserved ~800 bp region is located ~1Mb upstream
from its target gene, sonic hedgehog (SHH, OMIM 600725),
and acts as the enhancer of SHH.15 The ZRS normally
controls the expression of SHH in the zone of polarizing
activity (ZPA) located along the posterior margin of the limb
bud.16,17 Point variants and duplications in the ZRS are
associated with ectopic expression of SHH in the anterior
limb bud and usually result in a PPD phenotype.14,18
However, the potential mechanisms through which specific
ZRS variants impact ectopic expression of SHH in the
pathophysiology of PPD have only been partially clarified.
In this study, we report the first case of isolated PPD I in a
four-generation Chinese family that is associated with a novel
pathogenic variation, g.101779T>A in the LMBR1 gene
(reference sequence: NG_009240.2; position 446 of the ZRS
sequence). We generated a mouse model harboring the
g.67973T>A in the Lmbr1 gene (reference sequence:
NC_000071.6; position 447 of the mouse ZRS sequence), a
variant analogous to the T446A variant associated with PPD I
in humans. This novel model exhibited a distinct PPD I
phenotype with anterior ectopic expression of Shh in the
E11.5 limb buds. In vitro functional studies implicated
HnRNP K, which binds both the ZRS region and the SHH
promoter. This genetic variant enhanced HnRNP K's binding
potential to its target in ZRS and promoted SHH upregula-
tion, which may be associated with PPD I.
MATERIALS AND METHODS
Patient information
A four-generation pedigree with PPD I, including 31 Chinese
Han individuals from Guangdong Province, was identified
(Fig. 1a). Twenty-six family members (8 affected members, 8
normal members, and 10 undefined members) participated in
this study. PPD I was diagnosed based on family history,
physical examination, and X-ray examination and was
classified according to the criteria.2,19 DNA samples were
extracted from peripheral blood using QIAamp DNA blood
mini kits (Qiagen, Germany). The study was approved by the
First Affiliated Hospital Medical and Animal Ethics Commit-
tee of Sun Yat-sen University (MEC-2015-76). Each human
participant signed an informed consent form.
Genotyping and genetic analysis
DNA samples from 11 family members (II-3, II-4, II-7, II-8,
II-11, II-12, III-4, III-5, III-8, III-11, and IV-1) (Fig. 1a) were
subjected to genome-wide genotyping using the Illumina
HumanOmni2.5-Quad Beadchip by the Microarray Core at
University of Texas Southwestern Medical Center (UTSW).
Data were analyzed using GenomeStudio software (v. 2011.1).
We first selected 7037 single-nucleotide polymorphisms
(SNPs) across the autosomes from the ~2.5 million SNPs to
construct a sparse linkage map. The selected SNPs were
spaced ~2 per centiMorgan. A genome-wide affected-only
model-free linkage analysis was performed.20 Linked regions
were further evaluated by multipoint model-based linkage
analysis using both affected and unaffected individuals,
assuming a dominant model. Copy-number variation analysis
in the linked region was performed using cnvPartition
implemented in GenomeStudio. Genome-wide linkage analy-
sis revealed five linked regions on chromosomes 1p13, 4q35,
7q36, 10p15, and 21q21 (Supplementary Fig. 1). Noting that
the ZRS locus is directly underneath the linkage peak on
chromosome 7, we sequenced the ZRS locus in the LMBR1
using the Big Dye Terminator Cycle Sequence Kit 3.1 (ABI,
Foster City, CA, USA). The primers used are listed in
Supplementary Table 1. We also sequenced the ZRS locus
from 50 healthy unrelated age- and sex-matched Chinese Han
control subjects.
Mouse model
A C57BL/6 mouse model with a point variant (T447A)
located in introns 5–6 of the mouse Lmbr1 (NM_020295.3;
Ensembl: ENSMUSG00000010721) locus was created by
Cyagen Biosciences (Suzhou, China) with CRISPR/Cas9-
mediated genome engineering. The targeting strategy as well
as single guide RNA (sgRNA) and oligo donor designs are
shown in Supplementary Fig. 2. After coinjected, the pups
were genotyped by polymerase chain reaction (PCR), followed
by sequence confirmation (Supplementary Table 2). Skeletal
staining of postnatal day (P) 30 mice was conducted as
previously reported.21 The PPD incidence of each genotype
was calculated according to the phenotype of 368 mice.
E11.5 limb buds were divided into anterior halves and
posterior halves. Messenger RNA (mRNA) of each half was
extracted and real-time PCR was performed to compare the
expression of Shh and Hnrnpk among the three genotypes.
The sequences of the primers are shown in Supplementary
Table 6.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed using a LightShift Chemiluminescent
EMSA kit (Pierce, Rockford, IL, USA) with nuclear extracts
from Caco-2 cells. The mutant and wild-type 29-bp DNA
probes (Supplementary Table 3) were synthesized by
Integrated DNA Technologies (Coralville, IA, USA). Biotin-
labeled DNA was visualized by chemiluminescence. In the
supershift assay, for depletion, the following antibodies (1 µl)
were added along with the nuclear extract in a 10-µl reaction
system: HnRNP K (ab70492, Abcam), hnRNP A/B (sc98810,
Santa Cruz), hnRNP Q (ab10687, Abcam), HnRNP D
(ab61193, Abcam), and control IgG (ab46540, Abcam).
DNA pulldown and mass spectrometry (MS)
The biotinylated human SHH promoter probe was generated
by PCR. The WT-ZRS and MT-ZRS probes, and negative
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Fig. 1 A ZRS point variant is responsible for the pathogenesis of isolated preaxial polydactyly (PPD) I in a four-generation pedigree. (a) Pedigree of
isolated PPD I, showing autosomal dominant inheritance with near complete penetrance. Circles denote females and squares denote males. Filled symbols
represent affected individuals. Unfilled symbols represent unaffected individuals. Question marks represent undetermined individuals. The arrow indicates the
proband. Symbols with slashes represent deceased individuals. Asterisks indicate that a variant is present.WTwild-type. (b) Depicted are normal and X-ray images
of both hands in affected, undetermined, and normal individuals. (c) A T/A point variant at position 446 of the the ZRS was identified by Sanger sequencing.
XU et al ARTICLE
GENETICS in MEDICINE | Volume 22 | Number 1 | January 2020 191
control probes LacZ were synthesized by Bersin Bio
(Guangzhou, China). The primers are shown in Supplemen-
tary Table 4. A DNA pulldown assay was performed as
described previously22 using Caco-2 cells. For liquid
chromatography–tandem mass spectrometry (LC-MS/MS)
analyses, a Q-Exactive mass spectrometer (Thermo 588
Finnigan, San Jose, CA, USA) coupled with an Easy-
nLC1000 HPLC system 589 (Thermo Fisher, San Jose, CA,
USA) was used as described previously.23 Sonar tandem MS
software was used for protein identification.
Plasmid construct and transfection
Full-length human HnRNP K complementary DNA (cDNA)
(GenBank accession number NM_031262) was introduced
into the XhoI/KpnI site of the GV219 vector plasmid.
GV219 was used as control. The human HnRNP K
small interfering RNA (siRNA) and scrambled siRNA
(Supplementary Table 5) were synthesized by Bersin Bio
(Guangzhou, China). Caco-2 and 293T cells were transfected
with plasmid or siRNA (20 nM) using Lipofectamine
3000 (Invitrogen). The efficiency of the transfection was
assessed as previously described.24 Primer sequences are
described in Supplementary Table 6. The following primary
antibodies were used: anti-HnRNP K (ab70492, Abcam), anti-
SHH (06–1106, Millipore), and anti-GAPDH (EarthOx,
Millbrae, CA, USA). The identification results using the
HnRNP K siRNAi are shown in Supplementary Fig. 3.
HnRNP K siRNAi3 was used for the EMSA assay and SHH
regulation study.
Chromatin immunoprecipitation (ChIP) assays
Mononuclear cells from the peripheral blood of patients with
PPD I or normal members were isolated and purified
by density gradient centrifugation using Ficoll-Hypaque
(1.077 g/ml) (TBD, China). ChIP assays were performed
using a Magna ChIP™ Kit (Millipore). Briefly, mononuclear
cells (1 × 107) were cross-linked and lysed. The sheared
chromatin was incubated with an anti-hnRNP K antibody
and magnetic protein A/G beads (Millipore). The IgG
(ab46540, Abcam) was used as control. The immune
complexes were purified and further analyzed using quanti-
tative PCR for the ZRS and SHH promoter. SHH promoter
sequence (−849 ~+12) was divided into ten different SHH
promoter segment sequences, from SHH-1 to SHH-10. The
different sequences and the primer sequences are provided
in Supplementary Table 6. The MMP12 promoter region
(−95 to −20) was used as a positive control.25
Dual-luciferase reporter assay
Vector plasmids bearing the human SHHminimal promoter26
(CS-NEG-GA03-02), ZRS-SHH promoter (CS-ZRS01-GA03),
or mutant ZRS-SHH promoter reporter (CS-ZRS02-GA03)
were constructed, packaged, and purified by GeneCopoeia
(Guangzhou, China), and 293T cells were cotransfected with
siRNAs corresponding to HnRNP K and the SHH promoter,
ZRS-SHH promoter, or mutant ZRS-SHH promoter reporter.
Luciferase activity was measured using a Secrete-Pair Dual
Luminescence Assay Kit (GeneCopoeia, China).
Statistical analysis
Statistical analysis was performed using the statistical software
SPSS13. Results are expressed as mean ± standard deviation
(s.d.) and analyzed for significant differences using analysis
of variance (ANOVA) and Student’s t test. P < 0.05 was
considered significant (*p < 0.05, **p < 0.01).
RESULTS
PPD I phenotypes in the index family
The disease manifested variable phenotypes in an autosomal
dominant pattern of inheritance in the index pedigree. Eight
family members (II-3, II-7, II-11, III-4, III-8, III-11, III-12,
and IV-1) of this four-generation family were defined as
affected individuals (Fig. 1a). The left thumbs of affected
members II-11 and IV-1 showed duplication of the distal
phalanx, typical of PPD I and Wassel type II according to
Wassel’s classification system19 (Fig. 1b). The right thumbs of
II-11, IV-1, III-12 (Fig. 1b), and both thumbs of another four
affected members (II-7, III-4, III-8 [Fig. 1b], and III-11
[Fig. 1b]) exhibited incomplete duplication of the distal
phalanx. The left thumb of III-12 (Fig. 1b) was normal. There
were small sesamoids located between two phalanges of the
bilateral thumbs of individuals II-2 (Fig. 1b), II-5, II-9
(Fig. 1b), II-13, III-2, III-6, III-7, III-9, III-10, and III-13, who
were classified as undefined members. We examined an
additional 50 hands of trauma patients with normal X-rays
and found 9 with sesamoids similar to those in the members
in our pedigree. Members II-4, II-6, II-8, II-12, II-14, III-1,
III-5, and III-14 were defined as unaffected individuals
(Fig. 1a) with a normal phenotype (Fig. 1b). The affected
family members did not have any other apparent congenital
anomalies. The clinical features from affected individuals in
PPD I pedigree are shown in Supplementary Table 7.
Identification of a point variant in the ZRS
A genome-wide affected-only model-free linkage screen
identified five linked regions: 1p13, 4q35, 7q36, 10p15, and
21q21. Model-based linkage analysis under a dominant model
with a penetrance of 0.95, sporadic rate of 0.01, and disease-
predisposing allele frequency of 0.001 confirmed the results of
the model-free analysis and generated a maximum logarithm
of the odds (LOD) score of ~1.75 in each linked region
(Supplementary Fig. 1). There were no copy-number varia-
tions cosegregating with disease in the five regions. Of note,
the ZRS locus was directly underneath the linkage peak on
chromosome 7.
Sequencing a 1.28-kb region covering the ZRS on chromo-
some 7 revealed a heterozygous T>A point variant at 446 bp
of the ZRS in all affected members and an undefined member,
III-9 (Fig. 1a, c and Supplementary Fig. 4). All unaffected
members and other undefined members from this family were
homozygous T/T (Fig. 1a, c). This variant was not found in
ExAC, gnomAD, or in the 50 healthy controls.
ARTICLE XU et al
192 Volume 22 | Number 1 | January 2020 | GENETICS in MEDICINE
Point variant (g.67973T>A) at mouse Lmbr1 leads to a PPD I
phenotype and excess Shh expression in the developing
limb bud
To further explore the functional consequences of this variant, a
g.67973T>A knockin (homologous position in mouse to human
g.101779T>A) at the mouse Lmbr1 locus was engineered in
C57BL/6 mouse (Supplementary Fig. 2). The resulting hetero-
zygous mice exhibited extra preaxial digits only in the
hindlimbs and not in the forelimbs (Fig. 2a, ZRS+/−). Most
homozygotes (62%) exhibited extra preaxial digits only on the
hindlimbs and 38% of those ZRS−/− mice exhibited extra
digits on both the hindlimbs and forelimbs (Fig. 2a, ZRS−/−).
All wild-type mice exhibited normal preaxial digits (Fig. 2a,
ZRS+/+). The penetrance of heterozygous mice was 81% (150/
185), compared with 100% in homozygous mice (92/92)
(Fig. 2b and Supplementary Table 8). No other apparent
abnormalities were observed in the heterozygous or
homozygous mice. Analysis of Shh expression in the
developing limb buds at E11.5 by quantitative (qPCR) showed
that Shh is only expressed in the posterior of developing limb
buds in wild-type mouse. Both the heterozygous and
homozygous mutant result in ectopic anterior expression
and increased posterior expression of Shh compared with
wild-type mouse. The Shh expression level in homozygous
mutant mouse was the highest among three genotypes
(Fig. 2c). Our results show that the g.67973T>A variant in
murine Lmbr1 leads to ectopic anterior and increased
posterior expression of Shh and a PPD I phenotype in mouse.
Protein-binding differences between mutant and wild-type
ZRS
The protein-binding profile associated with the 29-bp
motif encompassing T446A variant on ZRS was analyzed by
EMSA. The results showed a specific DNA/protein-binding
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Fig. 2 Point variant (T447A) in mouse ZRS leads to a preaxial polydactyly (PPD) I phenotype and excess shh expression in the developing limb
bud. (a) Whole-mount skeletal specimens from postnatal day (P) 30 of transgenic mouse were stained using Alizarin red and Alcian blue. The extra preaxial
digit was identified on the hindlimbs of heterozygous mouse (ZRS+/−). Homozygous mouse (ZRS−/−) showed extra preaxial digits in both hindlimbs
and forelimbs or only in hindlimbs. Preaxial digits are indicated by red arrows. (b) The penetrance statistical analysis of polydactyly among wild-type mouse
(ZRS+/+), heterozygous mouse (ZRS+/−), and homozygous mouse (ZRS-/-). (c) Real-time polymerase chain reaction (PCR) was performed to compare the
expression of Shh in the anterior and posterior halves of E11.5 limb buds among wild-type mouse (ZRS+/+), heterozygous mouse (ZRS+/−), and homozygous
mouse (ZRS−/−). Data represent mean ± SD. *p < 0.05, significantly different from control (n= 3). mRNA messenger RNA.
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band for the wild-type probe and mutant probe at the same
position, but the mutant probe exhibited enhanced binding
intensity compared with the wild-type probe (Fig. 3a, L2 and
L5). The binding specificity was demonstrated using unla-
beled competitors for either the wild-type or mutant probes
(Fig. 3a, L3 and L6).
Identification of HnRNP K binding to the ZRS and the
promoter of SHH
To identify the specific proteins binding to the ZRS, we
employed DNA pulldown and MS assays to analyze the
binding protein components. As a result, several protein
members from the heterogeneous nuclear ribonucleoprotein
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(HnRNPs) family, including HnRNP K, HnRNP A/B,
HnRNP Q, and HnRNP D, were identified among the specific
binding proteins (Supplementary Figs. 5, 6, and Supplemen-
tary Table 9), whereas those proteins were not captured with a
negative control probe (Supplementary Table 10). To
determine the candidate HnRNPs specifically binding to the
ZRS sequences, a supershift assay was performed using
antibodies specific for HnRNP K, HnRNP A/B, HnRNP Q,
and HnRNP D proteins. Only the anti-HnRNP K antibody
depleted specific protein binding to the mutant DNA probe
(Fig. 3b, Supplementary Fig. 7). To further investigate the
binding specificity of HnRNP K to the mutant ZRS, we
constructed HnRNP K knockdown (Fig. 3c, d) and over-
expression models (Fig. 3e, f) in Caco-2 cells. The EMSA
results showed that both the wild-type and mutant probes
bound more protein in HnRNP K–overexpressing cells than
that in control cells (Fig. 3g, L1–L4). In contrast, both the
wild-type and mutant probes bound less protein from
HnRNP K knockdown cells (Fig. 3g, L5–L8). However, the
mutant probes exhibited higher binding efficiency with
HnRNP K in both cells compared with wild-type probes
(Fig. 3g)
To test if HnRNP K binds directly to the mutant site on
ZRS, we performed ChIP using nuclear extracts isolated from
mononuclear cells of patients with PPD I or unaffected family
members. We observed that the HnRNP K antibody
precipitated more of the ZRS sequence from mutant cells
than from normal cells (Fig. 3h). These results suggested that
HnRNP K indeed binds the ZRS and has a stronger binding
affinity to the mutant ZRS than the wild-type ZRS.
Interestingly, the HnRNP K and HnRNP U proteins were
also pulled down by the promoter probe of SHH, as shown by
the MS result (Supplementary Fig. 8 and Supplementary
Table 9). A ChIP-qPCR assay further confirmed that the
HnRNP K antibody precipitated the promoter sequence
(−668 ~−596) of SHH (Fig. 3i).
HnRNP K mediates the ZRS variant regulating the
transcriptional activity of SHH
To determine whether the ZRS variant regulates the
transcriptional activity of SHH and whether HnRNP K
mediates the abnormal SHH expression by the ZRS variant, a
dual-luciferase reporter assay was performed. The results
showed that both wild-type and mutant ZRS significantly
increased luciferase activity compared with the promoter-only
control; however, the mutant ZRS had increased luciferase
activity more dramatically compared with the wild-type ZRS
(Fig. 4b). This observation indicated that the wild-type ZRS
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harbored a potential enhancer of SHH. Furthermore, the
mutant ZRS had stronger enhancing activity than the wild-
type ZRS. Cotransfection with HnRNP K siRNA and SHH
promoter plasmids showed that HnRNP K knockdown not
only inhibited the activity of the SHH promoter, but it also
completely inhibited the WT- or mutant ZRS-enhanced SHH
promoter activity (Fig. 4c). In addition, HnRNP K over-
expression or knockdown in 293T cells resulted in a
corresponding increase or decrease in SHH both at the
mRNA (Fig. 4d, f) and protein levels (Fig. 4e, g). Combined
with the results of HnRNP K binding both the ZRS and the
promoter of SHH (from the MS studies), we propose that
HnRNP K mediates the ability of the variant ZRS to
upregulate SHH by directly interacting with the ZRS and
the SHH promoter.
DISCUSSION
PPD I is a common form of polydactyly. PPD I cases are
mostly sporadic,27,28 which may be the reason why the genes
responsible for it have not yet been identified. In this study,
we recruited a four-generation Chinese family with familial
isolated PPD I; this family provided us with the opportunity
to identify a predisposing variant in individuals with PPD I.
In this family, the affected members show phenotypic
variation from typical thumb duplication of the distal phalanx
or incomplete thumb duplication to slight sesamoids between
the two phalanges of the thumbs. However, III-9 with
heterozygous variant manifests small sesamoids, which are
found in normal members II-2, II-5, II-9, II-13, III-2, III-6,
III-7, III-10, and III-13. Hence, the variant in our PPD family
shows incomplete penetrance. The 295C>T variant in ZRS
(chr7:156,584,275, hg19) associated with PPD II in multiple
English families also shows incomplete penetrance,29 which is
consistent with our result. The incomplete penetrance was
also observed in our mouse model. The penetrance of
heterozygotes was 81% (150/185), compared with 100% in
homozygotes (92/92) (Supplementary Table 9). Haploinsuffi-
ciency caused by heterozygous variant might account for the
variable penetrance.
In this study, we showed that a T/A point variant at 446 bp
of ZRS led to PPD I; this is the first report identifying the
genetic variation causing isolated PPD I. However, follow-up
sequencing in another seven sporadic PPD I patients from
different families did not identify a variant in the ZRS. One
possible reason is that the sporadic PPD I may be caused by
other genetic mechanisms. The generic term “ZRS-associated
syndromes” for limb malformations caused by variants of ZRS
has been suggested,30 and our study will assist in developing
this new genetic classification system for PPD.
The ZRS is a highly conserved region in mammals. To date,
variants associated with most PPD types are scattered through
the ~800-bp ZRS region. Experiments in animal models
showed that these variants can cause ectopic anterior
expression of SHH, leading to ectopic digits.31 In our study,
the new T>A replacement at position 447 of the ZRS
(at position 446 of the human ZRS) also resulted in ectopic
anterior expression of Shh in the hindlimbs, which is in
agreement with previous reports.
The molecular mechanisms by which ZRS regulates SHH
expression remain largely unknown. Studies have suggested
that variants might change the affinities of certain transcrip-
tion factors (TFs) to their binding sites within the ZRS,
thereby activating SHH expression at an ectopic site in the
limb bud.13,32 For example, there are CDX, ETS factor family,
SOX9, and HnRNP U binding sites in the ZRS region and
these TFs play distinct roles in the spatial patterning of
SHH.33,34 The developing limb buds are preferable for
studying the interaction between protein with the ZRS.
However, it is difficult to extract E11.5 limb bud nucleopro-
tein. In this study, we selected the Caco-2 cell line to search
for the possible binding protein to the ZRS. Caco-2 cells do
express SHH in both differentiated and undifferentiated
stages.32 It has been investigated whether the TF-binding
properties of the mutated ZRS differs from those of the wild
type.32 In contrast to primary fibroblasts or immortalized
limb mesenchymal cell lines,35 Caco-2 is more freely available.
The results from Caco-2 cells confirmed that HnRNP K binds
to the mutant ZRS and that binding differences exist between
mutant and wild-type ZRS. HnRNP K, a nucleic acid binding
protein, has been identified as a component of hnRNP
complexes. HnRNP K play an important role in chromatin
organization and transcription.36,37 It possesses sequence-
specific binding activity, interacting with both single- and
double-stranded DNA, which makes HnRNP K a good
candidate for a long-distance transcription factor regulator.38
Here, we provided the first strong evidence confirming that
HnRNP K not only preferentially binds the mutant ZRS
compared with the wild-type ZRS, but it also binds the
promoter of SHH. The dual-luciferase reporter assay further
confirmed that HnRNP K knockdown not only inhibited the
activity of the SHH promoter but also completely inhibited
the enhancement of the SHH promoter by wild-type or
mutant ZRS. Kline et al. reported that a syndrome due to loss-
of-function variants in HNRNPK includes finger clinodactyly,
postaxial polydactyly, and multiple vertebral segmentation
defects.39 The current molecular data suggest that the balance
between the activation and repression of SHH signaling
specifies digit number as well as a polarization of digit
identity.40 The abnormal activation or repression of SHH
signaling in the limb bud can cause preaxial or postaxial
polydactyly respectively.40 Therefore, we speculate that the
loss-of-function variants in HNRNPK might repress the
activity of SHH and lead to postaxial polydactyly. While in
our case, mutant ZRS binds more HnRNP K, which then
strengthens SHH transcription and may cause PPD I. Neither
postaxial polydactyly nor clinodactyly were observed in our
patients.
Nevertheless, our study has some limitations to be
addressed in future studies. First, our model does not examine
the HnRNP K binding and regulating the ZRS in vivo due to
the difficulties of getting enough limb buds from mouse
embryos. It would be more convincing to perform EMSA and
ARTICLE XU et al
196 Volume 22 | Number 1 | January 2020 | GENETICS in MEDICINE
chip assay with limb bud nuclear extract, as in Lettice et al.33
Second, we did not propose a possible model to explain how
the point variant leads to ectopic expression of Shh mediated
by HnRNP K. In previous existing models of ETS transcrip-
tion factors and ZRS action,33 GABPα and ETS1 binding ZRS
can activate the transcription of Shh and are expressed mainly
in the posterior limb, while ETV4 and ETV5 binding ZRS
repress the transcription of Shh and are expressed in both the
posterior and anterior limb. When the variant occurs, an
increase in the binding sites of the activating ETS factors and
a decrease in the binding sites of the repressing ETS factors
can lead to Shh ectopic expression, while our study shows that
HnRNP K binding mutant ZRS can activate SHH expression.
However, there is no difference in the Hnrnpk expression
between the posterior and anterior part whatever the
genotype (Supplementary Table 9). Therefore the underlying
mechanism is not consistent with the reported model and
needs further confirmation.
In summary, for the first time, we report a genetic variation
that causes PPD I. We further show that the point variant
changed the binding affinity of HnRNP K to its target in the
ZRS in vitro and also leads to ectopic anterior and increased
posterior expression of Shh in developing mouse embryonic
limbs. Furthermore, HnRNP K was identified for the first
time binding both the promoter of SHH and its long-range
cis-regulator ZRS. In vitro functional studies further showed
that HnRNP K mediates the regulation of abnormal SHH
expression via the ZRS variant by changing its interaction
with the ZRS, which may be associated with the PPD I. The
identification of additional long-range cis-regulatory elements
and their related binding factors, as well as genetic
information from noncoding genomic regions, will augment
our understanding of how aberrant temporal and spatial
expression of SHH may lead to polydactyly.
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